Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Athira Pharma Inc.

    NASDAQ: ATHA · Real-Time Price · USD
    0.36
    0.02 (5.51%)
    At close: Jun 06, 2025, 3:58 PM
    0.36
    0.45%
    After-hours: Jun 06, 2025, 05:56 PM EDT

    Athira Pharma Statistics

    Share Statistics

    Athira Pharma has 39.04M shares outstanding. The number of shares has increased by 1.86% in one year.

    Shares Outstanding

    n/a
    		 39.04M

    Shares Change (YoY)

    n/a
    		 1.86%

    Shares Change (QoQ)

    n/a
    		 0.97%

    Owned by Institutions (%)

    n/a
    		 46.58%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,511

    FTD / Avg. Volume

    n/a
    		 0.27%

    Short Selling Information

    The latest short interest is 749.78K, so 1.92% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 749.78K

    Short % of Shares Out

    n/a
    		 1.92%

    Short % of Float

    n/a
    		 2.29%

    Short Ratio (days to cover)

    n/a
    		 3.32

    Valuation Ratios

    The PE ratio is -0.23 and the forward PE ratio is -0.75. Athira Pharma's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.23

    Forward PE

    n/a
    		 -0.75

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.5

    P/FCF Ratio

    n/a
    		 -0.23

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Athira Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 4.18

    Quick Ratio

    n/a
    		 4.18

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,728,461.54

    Employee Count

    n/a
    		 26

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -86.61% in the last 52 weeks. The beta is 3.03, so Athira Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 3.03

    52-Week Price Change

    n/a
    		 -86.61%

    50-Day Moving Average

    n/a
    		 0.27

    200-Day Moving Average

    n/a
    		 0.6

    Relative Strength Index (RSI)

    n/a
    		 65.08

    Average Volume (20 Days)

    n/a
    		 560,344

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -96.78M

    Net Income

    n/a
    		 -96.94M

    EBITDA

    n/a
    		 -95.97M

    EBIT

    n/a
    		 -96.94M

    Earnings Per Share (EPS)

    n/a
    		 -2.52
    Full Income Statement

    Balance Sheet

    The company has 48.44M in cash and 1.22M in debt, giving a net cash position of 47.22M.

    Cash & Cash Equivalents

    n/a
    		 48.44M

    Total Debt

    n/a
    		 1.22M

    Net Cash

    n/a
    		 47.22M

    Retained Earnings

    n/a
    		 -406.15M

    Total Assets

    n/a
    		 43.51M

    Working Capital

    n/a
    		 34.36M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -97.17M and capital expenditures -33K, giving a free cash flow of -97.2M.

    Operating Cash Flow

    n/a
    		 -97.17M

    Capital Expenditures

    n/a
    		 -33K

    Free Cash Flow

    n/a
    		 -97.2M

    FCF Per Share

    n/a
    		 -2.53
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ATHA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ATHA is $11.25, which is 3208.8% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $11.25

    Price Target Difference

    n/a
    		 3208.8%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -17.29

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist